Literature DB >> 6245761

Electrophysiological identification of mesencephalic ventromedial tegmental (VMT) neurons projecting to the frontal cortex, septum and nucleus accumbens.

J M Deniau, A M Thierry, J Feger.   

Abstract

The electrophysiological properties of neurons located in the mesencephalic ventromedial tegmentum (VMT) and the organization of the efferents of these neurons to the frontal cortex, the septum, the nucleus accumbens and the head of the striatum were studied in ketamine-anesthetized rats. The projections of the VMT cells were determined through use of the antidromic activation method. Our results show that VMT projections to different target areas originate mainly from different VMT neurons. However, in some cases single VMT neurons were found to send axon collaterals to two different areas. Three branching patterns were observed: septum-cortex, septum--nucleus accumbens and septum--striatum. The occasional observation of temporally distinct antodromic responses from a single area was considered to result from activation of different branches of the arborizing axon. The distribution of antidromic response latencies for VMT projections to each structure is discussed in relation to the question of dopaminergic versus non-dopaminergic mesolimbic and mesocortical systems.

Entities:  

Mesh:

Year:  1980        PMID: 6245761     DOI: 10.1016/0006-8993(80)90093-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).

Authors:  J D Lane
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  Role of the head of the caudate nucleus and the orbital cortex in neuronal activity of tegmentum of the midbrain in a food reflex in cats.

Authors: 
Journal:  Neurosci Behav Physiol       Date:  1997 Sep-Oct

3.  The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain.

Authors:  Natalia Gorelova; Patrick J Mulholland; L Judson Chandler; Jeremy K Seamans
Journal:  Cereb Cortex       Date:  2011-06-10       Impact factor: 5.357

4.  Widespread cortical projections of the ventral tegmental area and of other brain stem structures in the cat.

Authors:  H J Markowitsch; E Irle
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

5.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

6.  Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.

Authors:  Elyssa B Margolis; Jennifer M Mitchell; Junko Ishikawa; Gregory O Hjelmstad; Howard L Fields
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

7.  Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization.

Authors:  S Murase; J M Mathé; J Grenhoff; T H Svensson
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  GABAergic mechanisms within the ventral tegmental area: involvement of dopaminergic (A 10) and non-dopaminergic neurones.

Authors:  L Stinus; J P Herman; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system.

Authors:  Matthew C Hearing; Anastasia N Zink; Kevin Wickman
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

10.  The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.

Authors:  L Arborelius; K Chergui; S Murase; G G Nomikos; B B Höök; G Chouvet; U Hacksell; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.